AUSTIN, Texas (AP) _ Aeglea Biotherapeutics Inc. (AGLE) on Tuesday reported a loss of $17.2 million in its first quarter.
On a per-share basis, the Austin, Texas-based company said it had a loss of 59 cents.
Aeglea shares have dropped 6.5% since the beginning of the year. The stock has declined 28% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGLE at https://www.zacks.com/ap/AGLE